Literature DB >> 24924661

Association between leaflet fusion pattern and thoracic aorta morphology in patients with bicuspid aortic valve.

Bryce A Merritt1, Alexander Turin, Michael Markl, S Chris Malaisrie, Patrick M McCarthy, James C Carr.   

Abstract

PURPOSE: To determine if patients with certain bicuspid aortic valve (BAV) phenotypes are predisposed to particular morphological abnormalities of the thoracic aorta.
MATERIALS AND METHODS: One hundred ninety-two patients with BAV who underwent magnetic resonance angiography between January 2007 and July 2010 were retrospectively identified. Aortic morphology was examined through measurements of aortic size index at nine levels along the thoracic aorta, three-dimensional volume of the ascending aorta, vessel asymmetry, and assessment of aortic root morphology.
RESULTS: We found 140 patients (73%) with right and left coronary cusps (R-L) fusion, 46 patients (24%) with R-N fusion, and 6 patients (3%) with left and noncoronary cusps (L-N) fusion. Mean aortic volume in the proximal ascending aorta was significantly greater in R-L patients (0.93 versus 0.60 cm(3)/m(2); P < 0.01). R-N patients possessed greater aortic size index at the distal ascending aorta and proximal aortic arch, and were also significantly more likely to have Type 2 patterns of aortic dilatation.
CONCLUSION: Our results suggest that BAV with R-L fusion is associated with increased dimensions of the aortic root, while BAV with R-N fusion is associated with increased dimensions of the distal ascending aorta and proximal arch. Our findings illustrate the morphological heterogeneity that exists among BAV phenotypes.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  BAV; CMR; thoracic aorta

Mesh:

Year:  2013        PMID: 24924661     DOI: 10.1002/jmri.24376

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  The timing of elective ascending aortic aneurysm replacement for non-syndromic patients and the implication of bicuspid aortic valve-related aortopathy.

Authors:  Ali Khoynezhad
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Aortic Volumetry at Contrast-Enhanced Magnetic Resonance Angiography: Feasibility as a Sensitive Method for Monitoring Bicuspid Aortic Valve Aortopathy.

Authors:  Brian Trinh; Iram Dubin; Ozair Rahman; Marcos P Ferreira Botelho; Nicholas Naro; James C Carr; Jeremy D Collins; Alex J Barker
Journal:  Invest Radiol       Date:  2017-04       Impact factor: 6.016

3.  Patient-Specific Quantification of Normal and Bicuspid Aortic Valve Leaflet Deformations from Clinically Derived Images.

Authors:  Bruno V Rego; Alison M Pouch; Joseph H Gorman; Robert C Gorman; Michael S Sacks
Journal:  Ann Biomed Eng       Date:  2022-01-07       Impact factor: 4.219

4.  The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only version.

Authors:  Michael A Borger; Paul W M Fedak; Elizabeth H Stephens; Thomas G Gleason; Evaldas Girdauskas; John S Ikonomidis; Ali Khoynezhad; Samuel C Siu; Subodh Verma; Michael D Hope; Duke E Cameron; Donald F Hammer; Joseph S Coselli; Marc R Moon; Thoralf M Sundt; Alex J Barker; Michael Markl; Alessandro Della Corte; Hector I Michelena; John A Elefteriades
Journal:  J Thorac Cardiovasc Surg       Date:  2018-08       Impact factor: 5.209

5.  Altered DNA methylation indicates an oscillatory flow mediated epithelial-to-mesenchymal transition signature in ascending aorta of patients with bicuspid aortic valve.

Authors:  Hanna M Björck; Lei Du; Silvia Pulignani; Valentina Paloschi; Karin Lundströmer; Alexandra S Kostina; Cecilia Österholm; Anna Malashicheva; Anna Kostareva; Arturo Evangelista; Gisela Teixidó-Tura; Shohreh Maleki; Anders Franco-Cereceda; Per Eriksson
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

6.  Importance of bicuspid aortic valve phenotype on aortopathy.

Authors:  Evaldas Girdauskas; John A Elefteriades
Journal:  Ann Cardiothorac Surg       Date:  2022-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.